Confirmatory Results
Search for SARS-CoV-2 inhibitors in currently approved drugs to tackle COVID-19 pandemia
Jordi Rodon, Marc Noguera-Julian, Itziar Erkizia, Alfonso Valencia, Víctor Guallar, Jorge Carrillo, Julià Blanco, Joaquim Segalés, Bonaventura Clotet, Júlia Vergara-Alert, View ORCID ProfileNuria Izquierdo-Useros
doi: https://doi.org/10.1101/2020.04.23.055756
Jordi Rodon
1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, 08193 Bellaterra (Cerdanyola del Vallès), Spain
Marc Noguera-Julian
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
Itziar Erkizia
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
Alfonso Valencia
3Barcelona Supercomputing Center
4Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
Víctor Guallar
3Barcelona Supercomputing Center
4Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
Jorge Carrillo
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
Julià Blanco
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
5Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain
6University of Vic–Central University of Catalonia (UVic-UCC), Vic, Spain
Joaquim Segalés
7UAB, CReSA (IRTA-UAB), Campus de la UAB, 08193 Bellaterra (Cerdanyola del Vallès), Spain
8Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, UAB, 08193 Bellaterra (Cerdanyola del Vallès), Spain
Bonaventura Clotet
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
5Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain
6University of Vic–Central University of Catalonia (UVic-UCC), Vic, Spain
Júlia Vergara-Alert
1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, 08193 Bellaterra (Cerdanyola del Vallès), Spain
Nuria Izquierdo-Useros
2IrsiCaixa AIDS Research Institute, 08916, Badalona, Spain
5Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain
Posted April 24, 2020.
Search for SARS-CoV-2 inhibitors in currently approved drugs to tackle COVID-19 pandemia
Jordi Rodon, Marc Noguera-Julian, Itziar Erkizia, Alfonso Valencia, Víctor Guallar, Jorge Carrillo, Julià Blanco, Joaquim Segalés, Bonaventura Clotet, Júlia Vergara-Alert, Nuria Izquierdo-Useros
bioRxiv 2020.04.23.055756; doi: https://doi.org/10.1101/2020.04.23.055756
Search for SARS-CoV-2 inhibitors in currently approved drugs to tackle COVID-19 pandemia
Jordi Rodon, Marc Noguera-Julian, Itziar Erkizia, Alfonso Valencia, Víctor Guallar, Jorge Carrillo, Julià Blanco, Joaquim Segalés, Bonaventura Clotet, Júlia Vergara-Alert, Nuria Izquierdo-Useros
bioRxiv 2020.04.23.055756; doi: https://doi.org/10.1101/2020.04.23.055756
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)